Executive Vice President of R&D and Chief Scientific Officer at Noveome Biotherapeutics
Larry Brown, Sc.D., serves as the Executive Vice President of R&D and Chief Scientific Officer of Noveome Biotherapeutics.
He obtained his doctorate in Biochemistry and Bioengineering at the Massachusetts Institute of Technology under Prof. Robert Langer and trained in the late Dr. Judah Folkman’s laboratory in the Surgical Research Department of Childrens Hospital, Boston. He served as Vice President, Research at Baxter Healthcare Corporation and in scientific leadership roles at startup biotech companies. He maintains strong academic collaborations with MIT’s Deshpande Center for technological innovation.
Title: Targeted intranasal nose-to-brain delivery of a novel amnion cell-derived biotherapeutic product
- ST266, a complex, multi-component, neuroprotective and anti-inflammatory cytokine and growth factor mixture
- Targeted intranasal delivery to the cribriform plate bypasses the blood-brain barrier. Measurable delivery to the optic nerve and other brain tissues in rodents and non-human primates
- Demonstrated efficacy in animal models of optic neuritis and optic nerve crush enabling pathway to clinical testing